Review: The intersection of surfactant homeostasis and innate host defense of the lung: lessons from newborn infants

Abstract

The study of pulmonary surfactant, directed towards prevention and treatment of respiratory distress syndrome in preterm infants, led to the identification of novel proteins/genes that determine the synthesis, packaging, secretion, function, and catabolism of alveolar surfactant. The surfactant proteins, SP-A, SP-B, SP-C, and SP-D, and the surfactant lipid associated transporter, ABCA3, play critical roles in surfactant homeostasis. The study of their structure and function provided insight into a system that integrates the biophysical need to reduce surface tension in the alveoli and the innate host defenses required to maintain pulmonary structure and function after birth. Alveolar homeostasis depends on the intrinsic, multifunctional structures of the surfactant-associated proteins and the shared transcriptional regulatory modules that determine both the expression of genes involved in surfactant production as well as those critical for host defense. Identification of the surfactant proteins and the elucidation of the genetic networks regulating alveolar homeostasis have provided the basis for understanding and diagnosing rare and common pulmonary disorders, including respiratory distress syndrome, inherited disorders of surfactant homeostasis, and pulmonary alveolar proteinosis.

Keywords

pulmonary surfactant surfactant structure and function pathogen-associated molecular pattern molecules surfactant proteins respiratory distress syndrome

References

Kingma PS , Whitsett JA In defense of the lung: surfactant protein A and surfactant protein D. Curr Opin Pharmacol 2006; 6: 277-283.

Waters P. , Vaid M. , Kishore U. , Madan T. Lung surfactant proteins A and D as pattern recognition proteins. Adv Exp Med Biol 2009; 653: 74-97.

Kuroki Y. , Takahashi M. , Nishitani C. Pulmonary collectins in innate immunity of the lung. Cell Microbiol 2007; 9: 1871-1879.

Whitsett JA , Weaver TE Hydrophobic surfactant proteins in lung function and disease. N Engl J Med 2002; 347: 2141-2148.

Yang L. , Johansson J. , Ridsdale R. et al. Surfactant protein B propeptide contains a saposin-like protein domain with antimicrobial activity at low pH. J Immunol 2010; 184: 975-983.

Glasser SW , Senft AP , Whitsett JA et al. Macrophage dysfunction and susceptibility to pulmonary Pseudomonas aeruginosa infection in surfactant protein C-deficient mice. J Immunol 2008; 181: 621-628.

Augusto LA , Synguelakis M. , Johansson J. et al. Interaction of pulmonary surfactant protein C with CD14 and lipopolysaccharide . Infect Immun 2003; 71: 61-77.

Hillman NH , Kallapur SG , Pillow JJ et al. Airway injury from initiating ventilation in preterm sheep. Pediatr Res 2010; 67: 60-65.

Maeda Y. , Davé V. , Whitsett JA Transcriptional control of lung morphogenesis. Physiol Rev 2007; 87: 219-244.

10.

Morrisey EE , Hogan BLM. Preparing for the first breath: Genetic and cellular mechanisms in lung development. Dev Cell 2010; 18: 8-23.

11.

Wert SE , Whitsett JA , Nogee LM Genetic disorders of surfactant dysfunction. Pediatr Dev Pathol 2009; 12: 253-274.

12.

Whitsett JA , Wert SE , Weaver TE Alveolar surfactant homeostasis and the pathogenesis of pulmonary disease. Annu Rev Med 2010; 61: 105-119.

13.

Nogee LM , Garnier G. , Dietz HC et al. A mutation in the surfactant protein B gene responsible for fatal neonatal respiratory disease in multiple kindreds. J Clin Invest 1994; 93: 1860-1863.

14.

Shulenin S. , Nogee LM , Annilo T. , Wert SE , Whitsett JA , Dean M. ABCA3 gene mutations in newborns with fatal surfactant deficiency. N Engl J Med 2004; 350: 1296-1303.

15.

Deutsch GH , Young LR , Deterding RR et al. Diffuse lung disease in young children: application of a novel classification scheme. Am J Respir Crit Care Med 2007; 176: 1120-1128.

16.

Guillot L. , Carré A. , Szinnai G. et al. NKX2-1 mutations leading to surfactant protein promoter dysregulation cause interstitial lung disease in ‘brain-lung-thyroid syndrome’ . Hum Mutat 2009; 31: E1146-E1162.

17.

Trapnell BC , Carey BC , Uchida K. , Suzuki T. Pulmonary alveolar proteinosis, a primary immunodeficiency of impaired GM-CSF stimulation of macrophages. Curr Opin Immunol 2009; 21: 514-521.

18.

Trapnell BC , Whitsett JA , Nakata K. Pulmonary alveolar proteinosis. N Engl J Med 2003; 349: 2527-2539.

19.

Uchida K. , Nakata K. , Trapnell BC et al. High-affinity auto-antibodies specifically eliminate granulocyte-macrophage colony-stimulating factor activity in the lungs of patients with idiopathic pulmonary alveolar proteinosis. Blood 2004 ; 103: 1089-1098.

20.

Kitamura T. , Tanaka N. , Watanabe J. et al. Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor. J Exp Med 1999; 190: 875-880.

21.

Suzuki T. , Sakagami T. , Rubin BK et al. Familial pulmonary alveolar proteinosis caused by mutations in CSF2RA. J Exp Med 2008; 205: 2703-2710.

22.

Martinez-Moczygemba M. , Doan ML , Elidemir O. et al. Pulmonary alveolar proteinosis caused by deletion of the GM-CSFRalpha gene in the X chromosome pseudoautosomal region 1. J Exp Med 2008; 205: 2711-2716.

23.

Berclaz PY , Shibata Y. , Whitsett JA , Trapnell BC GM-CSF, via PU.1, regulates alveolar macrophage FcγR-mediated phagocytosis and the IL-18/IFN-γ-mediated molecular connection between innate and adaptive immunity in the lung. Blood 2002; 100: 4193-4200.

24.

Berclaz PY , Zsengellér Z. , Shibata Y. et al. Endocytic internalization of adenovirus, nonspecific phagocytosis, and cytoskeletal organization are coordinately regulated in alveolar macrophages by GM-CSF and PU.1. J Immunol 2002; 169: 6332-6342.

25.

Dreyfuss D. , Saumon G. Ventilator-induced lung injury: lessons from experimental studies. Am J Respir Crit Care Med 1998; 157: 294-323.

26.

Hillman NH , Moss TJ , Kallapur SG et al. Brief, large tidal volume ventilation initiates lung injury and a systemic response in fetal sheep. Am J Respir Crit Care Med 2007; 176: 575-581.

27.

Mingarro I. , Lukovic D. , Vilar M. , Pérez-Gil J. Synthetic pulmonary surfactant preparations: new developments and future trends. Curr Med Chem 2008; 15: 393-403.

28.

Ikegami M. , Carter K. , Bishop K. et al. Intratracheal recombinant surfactant protein D prevents endotoxin shock in the newborn preterm lamb. Am J Respir Crit Care Med 2006; 173: 1342-1347.

29.

Sato A. , Whitsett JA , Scheule RK , Ikegami M. Surfactant protein-D inhibits lung inflammation caused by ventilation in premature newborn lamb. Am J Respir Crit Care Med 2010 ; In press, doi:10.1164/rccm.200912-1818OC.

30.

Wispé JR , Clark JC , Warner BB et al. Tumor necrosis factor-alpha inhibits expression of pulmonary surfactant protein. J Clin Invest 1990; 86: 1954-1960.

31.

Bry K. , Lappalainen U. , Hallman M. Intraamniotic interleukin-1 accelerates surfactant protein synthesis in fetal rabbits and improves lung stability after premature birth. J Clin Invest 1997; 99: 2992-2999.

32.

Xu Y. , Ikegami M. , Wang Y. , Matsuzaki Y. , Whitsett JA Gene expression and biological processes influenced by deletion of Stat3 in pulmonary type II epithelial cells. BMC Genomics 2007; 8: 455.